Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic

Journal of Clinical Psychiatry

Volumn 74, Issue 2, 2013, Pages 149-155

  Gaudiano, Brandon A ^a   Zimmerman, Mark ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENUATED PSYCHOTIC SYNDROME; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DSM-IV; FEMALE; GENERAL HOSPITAL; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; MENTAL HOSPITAL; OUTPATIENT; OUTPATIENT DEPARTMENT; POST HOC ANALYSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SELF REPORT; SENSITIVITY AND SPECIFICITY; STRUCTURED INTERVIEW; SYMPTOM; UNITED STATES;

EID: 84874620735     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m07788     Document Type: Article

References (48)

1. DSM-5 Psychosis Workgroup. Attenuated Psychosis Syndrome. http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=412. Updated April 27, 2012. Accessed August 16, 2012.
2. Woods SW, Walsh BC, Saksa JR, et al. The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res. 2010;123(2-3):199-207. doi:10.1016/j.schres.2010.08.012 PubMed
3. Cornblatt BA, Correll CU. A new diagnostic entity in DSM-5? http://www.medscape.com/viewarticle/727682-print. Updated September 2, 2010. Accessed August 16, 2012.
4. Arango C. Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry. Eur Child Adolesc Psychiatry. 2011;20(2):67-70. doi:10.107/s0787-010-014-2 PubMed
5. Fusar-Poli P, Yung AR. Should attenuated psychosis syndrome be included in DSM-5? Lancet. 2012;379(9816):591-592. doi:10.1016/S0140-6736(1)61507-9 PubMed
6. Shrivastava A, McGorry PD, Tsuang M, et al. "Attenuated psychotic symptoms syndrome" as a risk syndrome of psychosis, diagnosis in DSM-V: the debate. Indian J Psychiatry. 2011;53(1):57-65. doi:10.4103/019-545.7560 PubMed
7. Carpenter WT, van Os J. Should attenuated psychosis syndrome be a DSM-5 diagnosis? Am J Psychiatry. 2011;168(5):460-463. doi:10.176/api.ajp.201.10121816 PubMed
8. Woods SW, Addington J, Cadenhead KS, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009;35(5):894-908. doi:10.1093/schbul/ sbp027 PubMed
9. Yung AR, Yuen HP, Berger G, et al. Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull. 2007;33(3):673-681. doi:10.1093/schbul/sbm015 PubMed (Pubitemid 47343718)
10. Yung AR, Buckby JA, Cotton SM, et al. Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability. Schizophr Bull. 2006;32(2):352-359. doi:10.1093/schbul/sbj018 PubMed
11. van Os J, Verdoux H, Maurice-Tison S, et al. Self-reported psychosis-like symptoms and the continuum of psychosis. Soc Psychiatry Psychiatr Epidemiol. 1999;34(9):459-463. doi:10.107/s012705020 PubMed (Pubitemid 29481684)
12. Loewy RL, Johnson JK, Cannon TD. Self-report of attenuated psychotic experiences in a college population. Schizophr Res. 2007;93(1-3):144-151. doi:10.1016/j.schres.207.02.010 PubMed (Pubitemid 46817933)
13. Werbeloff N, Drukker M, Dohrenwend BP, et al. Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Arch Gen Psychiatry. 2012;69(5):467-475. doi:10.101/archgenpsychiatry.201.1580 PubMed
14. Maxmen A. Psychosis risk syndrome excluded from DSM-5 [News]. Nature. Published May 9, 2012. Accessed September 6, 2012. doi:10.1038/nature.2012. 10610. htp:/w.com/news/psychosis-risk-syndrome-excluded-from-dsm-5-1.10610.
15. Zimmerman M. Integrating the assessment methods of researchers in routine clinical practice: the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project. In: First MB, ed. Standardized Evaluation in Clinical Practice. Washington, DC: American Psychiatric Association; 2003:29-74.
16. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry. 2001;58(8):787-794. doi:10.101/archpsyc.58.8.787 PubMed (Pubitemid 32717805)
17. Zimmerman M, Chelminski I. A scale to screen for DSM-IV Axis I disorders in psychiatric out-patients: performance of the Psychiatric Diagnostic Screening Questionnaire. Psychol Med. 2006;36(11): 1601-1611. doi:10.1017/S0329170608257 PubMed (Pubitemid 44575806)
18. Zimmerman M, Chelminski I. Screening for anxiety disorders in depressed patients. J Psychiatr Res. 2006;40(3):267-272. doi:10.1016/j.jpsychires.205.03. 01 PubMed (Pubitemid 43214634)
19. Sheeran T, Zimmerman M. Factor structure of the Psychiatric Diagnostic Screening Questionnaire (PDSQ), a screening questionnaire for DSM-IV Axis I disorders. J Behav Ther Exp Psychiatry. 2004;35(1):49-55. doi:10.1016/j.jbtep. 204.02.02 PubMed (Pubitemid 38638582)
20. Zimmerman M, Chelminski I, Posternak M. An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials. J Affect Disord. 2004;80(1):79-85. doi:10.1016/S0165-0327(03)050-8 PubMed (Pubitemid 38496532)
21. Zimmerman M, Sheeran T. Screening for principal versus comorbid conditions in psychiatric outpatients with the Psychiatric Diagnostic Screening Questionnaire. Psychol Assess. 2003;15(1):110-114. doi:10.1037/1040-3590.15.1.10 PubMed (Pubitemid 36314932)
22. Gibbons RD, Rush AJ, Immekus JC. On the psychometric validity of the domains of the PDSQ: an illustration of the bi-factor item response theory model. J Psychiatr Res. 2009;43(4):401-410. doi:10.1016/j.jpsychires.208.04.013 PubMed
23. First MB, Spitzer RL, Williams JBW, et al. Structured Clinical Interview for DSM-IV (SCID). Washington, DC: American Psychiatric Association; 2002.
24. Pfohl B, Blum N, Zimmerman M. Structured Interview for DSM-IV Personality: SIDP-IV. Washington, DC: American Psychiatric Association; 1997.
25. Spitzer R, Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS). 3rd ed. New York, NY: Biometric Research, New York State Psychiatric Institute; 1977.
26. Endicott J, Andreasen N, Spitzer RL. Family History Research Diagnostic Criteria. New York, NY: Biometric Research, New York State Psychiatric Institute; 1978.
27. Zimmerman M, Mattia JI. Psychiatric diagnosis in clinical practice: is comorbidity being missed? Compr Psychiatry. 1999;40(3):182-191. doi:10.1016/S010-40X(9)901-9 PubMed (Pubitemid 29237308)
28. Svirskis T, Korkeila J, Heinimaa M, et al. Axis-I disorders and vulnerability to psychosis. Schizophr Res. 2005;75(2-3):439-446. doi:10.1016/j.schres.204.1.02 PubMed (Pubitemid 40693075)
29. Rosen JL, Miller TJ, D'Andrea JT, et al. Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophr Res. 2006;85(1-3):124-131. doi:10.1016/j.schres.206.03.034 PubMed (Pubitemid 43947540)
30. Varghese D, Scott J, Welham J, et al. Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults. Schizophr Bull. 2011;37(2):389-393. doi:10.1093/schbul/sbp083 PubMed
31. Wigman JT, van Nierop M, Vollebergh WA, et al. Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity - implications for diagnosis and ultrahigh risk research. Schizophr Bull. 2012;38(2):247-257. doi:10.1093/schbul/ sbr196PubMed
32. Binbay T, Drukker M, Elbi H, et al. Testing the psychosis continuum: differential impact of genetic and nongenetic risk factors and comorbid psychopathology across the entire spectrum of psychosis [published online ahead of print April 27, 2011]. Schizophr Bull. doi:10.1093/schbul/sbr03 PubMed
33. van Rossum I, Dominguez MD, Lieb R, et al. Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull. 2011;37(3):561-571. doi:10.1093/schbul/ sbp101 PubMed
34. van Nierop M, van Os J, Gunther N, et al. Phenotypically continuous with clinical psychosis, discontinuous in need for care: evidence for an extended psychosis phenotype. Schizophr Bull. 2012;38(2):231-238. doi:10.1093/schbul/ sbr129 PubMed
35. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65(1):28-37. doi:10.101/archgenpsychiatry.207.3 PubMed
36. Yung AR, Phillips LJ, Yuen HP, et al. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res. 2004;67(2-3):131-142. doi:10.1016/S0920-(03)0192-0 PubMed (Pubitemid 38251443)
37. Nelson B, Yuen K, Yung AR. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Schizophr Res. 2011;125(1):62-68. doi:10.1016/j.schres.2010.10.017 PubMed
38. Koutsouleris N, Gaser C, Bottlender R, et al. Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis. Schizophr Res. 2010;123(2-3):175-187. doi:10.1016/j.schres.2010.08.032 PubMed
39. Koutsouleris N, Patschurek-Kliche K, Scheuerecker J, et al. Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis. Schizophr Res. 2010;123(2-3):160-174. doi:10.1016/j.schres.2010. 08.026 PubMed
40. Kaymaz N, Drukker M, Lieb R, et al. Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? a systematic review and meta-analysis, enriched with new results [published online ahead of print January 20, 2012]. Psychol Med. doi:10.1017/S03291710291 PubMed
41. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126(7): 983-987. PubMed
42. Jacobs E, Kline E, Schiffman J. Practitioner perceptions of attenuated psychosis syndrome. Schizophr Res. 2011;131(1-3):24-30. doi:10.1016/j.schres. 201.06.02 PubMed
43. Loewy RL, Bearden CE, Johnson JK, et al. The Prodromal Questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr Res. 2005;79(1):117-125. doi:10.1016/j. schres.205.03.07 PubMed
44. Müller M, Vetter S, Buchli-Kammermann J, et al. The Self-Screen- Prodrome as a short screening tool for pre-psychotic states. Schizophr Res. 2010;123(2-3):217-224. doi:10.1016/j.schres.2010.08.018 PubMed
45. Kline E, Wilson C, Ereshefsky S, et al. Convergent and discriminant validity of attenuated psychosis screening tools. Schizophr Res. 2012;134(1):49-53. doi:10.1016/j.schres.201.10.01 PubMed
46. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703-715. doi:10.1093/oxfordjournals. schbul.a07040 PubMed (Pubitemid 38181951)
47. Häfner H, Maurer K, Trendler G, et al. The early course of schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci. 2005;255(3):167-173. doi:10.107/s0406-05-0584-8 PubMed (Pubitemid 40922939)
48. van Os J, Linscott RJ, Myin-Germeys I, et al. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med. 2009;39(2):179-195. doi:10.1017/S0329170803814 PubMed